The global sore throat lozenges market size is USD 6.2 Billion in 2026.
The sore throat lozenges market is projected to grow at a 6% CAGR through 2033.
The sore throat lozenges market growth is driven by seasonal respiratory infections, pollution exposure, and rising demand for natural/functional formulations.
North America is the dominant region for the sore throat lozenges market.
Reckitt Benckiser, GlaxoSmithKline, Pfizer, Procter & Gamble, and Ricola are some leading industry players in the sore throat lozenges market.